Sector Outlook Therapeutics, Inc.

Aandelen

OTLK

US69012T3059

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 21:00:00 30-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,4681 USD -5,15% Intraday-grafiek van Outlook Therapeutics, Inc. -9,86% -70,37%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-5,15%-9,86%-18,38%-52,07%-70,37%-62,85%-96,10%-98,87%-99,93% 114 mln.
-0,62%-1,87%-15,14%+10,57%+56,67%+42,87%+64,15%+2,90% - 63,77 mld.
+0,35%+3,20%-4,68%+8,35%+12,61%+14,40%+81,76%+211,78%+5.665,71% 56,37 mld.
+0,53%+1,96%+12,00%+14,59%+19,78%+16,24%+103,35%-14,18%+244,86% 54,62 mld.
-2,81%-4,31%-0,57%+13,75%+18,60%+23,50%+47,83%+2,26%+272,64% 44,06 mld.
-0,33%-1,93%+1,20%+17,19%+21,90%+19,28%+98,80%+3,53%+1.014,11% 42,11 mld.
+0,55%+2,31%-6,80%+2,02%+140,19%+225,14%+866,21%+550,05% - 41 mld.
+3,27%+47,96%+66,97%+110,49%+92,99%+112,84%+96,58%+35,64%+249,91% 34,92 mld.
+1,22%-1,44%+7,82%+2,62%+11,15%+14,57%+46,95%+16,23%+156,74% 32,82 mld.
+0,89%+20,55%-1,37%+14,18%-35,31%-40,62%+349,24%+273,40%+767,33% 24,7 mld.
-1,29%-2,88%-20,64%+14,82%+41,48%+22,87%-8,48%-62,43% - 23,27 mld.
-1,08%+0,06%-10,31%-2,66%-7,38%-15,15%-5,74%-68,37% - 22,15 mld.
-3,77%-2,57%+4,46%+12,98%+16,09%+11,47%+168,68%+187,80%+2.146,76% 18,24 mld.
+4,82%+7,53%+18,80%+30,85%+58,32%+79,44%+237,01%+222,59%+555,24% 16,93 mld.
-4,44%+4,07%+21,83%+54,58%+80,17%+99,59%+113,48%-19,90%+373,66% 17,16 mld.
+0,73%+3,57%+16,96%+28,70%+40,58%+43,47%+83,40%-13,95%+111,94% 17 mld.
-0,68%+3,25%+10,29%+3,02% - - - - - 16,5 mld.
-1,91%+14,08%+24,34%+29,22%+15,99%+23,01%-13,36%-26,30%+163,28% 15,83 mld.
-4,03%+2,59%-2,06%+12,26%+180,86%+165,07%+354,23%+1.407,09%+801,47% 15,11 mld.
-7,22%+6,81%-11,82%+64,62%+22,30%-19,62% - - - 13,03 mld.
Gemiddelde -1,05%+4,73%+4,65%+19,50%+37,72%+40,82%+143,78%+144,96%+887,41% 28,48 mld.
Gewogen gemiddelde per kap. -0,41%+4,73%+4,31%+20,45%+41,67%+46,50%+157,23%+124,35%+1.261,16%
  1. Beurs
  2. Aandelen
  3. Koers OTLK
  4. Sector Outlook Therapeutics, Inc.